- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2466EUR$2,750USD£2,107GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2466EUR$2,750USD£2,107GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2466EUR$2,750USD£2,107GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2466EUR$2,750USD£2,107GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2466EUR$2,750USD£2,107GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2466EUR$2,750USD£2,107GBP
- Report
- February 2022
- 210 Pages
Global
From €6725EUR$7,500USD£5,746GBP
- Report
- June 2022
- 120 Pages
Global
From €4259EUR$4,750USD£3,639GBP
- Report
- June 2025
- 400 Pages
Global
From €4437EUR$4,949USD£3,791GBP
- Report
- June 2025
- 400 Pages
Global
From €4437EUR$4,949USD£3,791GBP
- Report
- June 2025
- 400 Pages
Global
From €4437EUR$4,949USD£3,791GBP
- Report
- June 2025
- 400 Pages
Global
From €4437EUR$4,949USD£3,791GBP
- Report
- July 2024
- 200 Pages
Global
From €4437EUR$4,949USD£3,791GBP
- Report
- February 2024
- 140 Pages
Global
From €4455EUR$4,969USD£3,807GBP
- Report
- May 2024
- 134 Pages
Global
From €2689EUR$2,999USD£2,298GBP
€3586EUR$3,999USD£3,064GBP
- Report
- May 2024
- 174 Pages
Global
From €2242EUR$2,500USD£1,915GBP
- Report
- July 2024
- 185 Pages
Global
From €2242EUR$2,500USD£1,915GBP
- Report
- May 2024
- 139 Pages
Global
From €2689EUR$2,999USD£2,298GBP
€3586EUR$3,999USD£3,064GBP
- Report
- July 2024
- 200 Pages
Global
From €4437EUR$4,949USD£3,791GBP
- Report
- August 2025
- 118 Pages
Global
From €16135EUR$17,995USD£13,786GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more